Tabrecta – capmatinib – approved for non-small cell lung cancer in adults
U.S. Food and Drug Administration approved Tabrecta (capmatinib) for the treatment of adult patients with non-small cell lung cancer (NSCLC) that has spread to other
Lung Cancer
Lung cancer is a disease in which the cells of the lung tissues grow uncontrollably and form tumors. There are two kinds of lung cancers, primary and secondary. Primary lung cancer (also called adenocarcinoma) starts in the lung itself. Primary lung cancer is divided into small cell lung cancer and non-small cell lung cancer, depending on how the cells look under the microscope. Secondary lung cancer is cancer that starts somewhere else in the body (for example, the breast or colon) and spreads to the lungs.
Breathalyzer test detects lung cancer 90% accuracy
Breathalyzer Test May Detect Deadliest Cancer — Researchers from TAU and partner institutions develop groundbreaking device that spots lung cancer – to stop it in its tracks – A new device developed by a team of Israeli, American, and British cancer researchers may turn the tide by both accurately detecting lung cancer and identifying its stage of progression.
Screen high risk populations for lung cancer – final lung cancer screening recommendations
Final recommendations on lung cancer screening — Final word: Task Force says screen high-risk populations for lung cancer – High-risk adults between the ages of 55 and 80 should receive annual lung cancer screening with low-dose computed tomography, according to final recommendations from the U.S. Preventive Services Task Force being published in Annals of Internal Medicine.
Colon cancer and rectal tumor constitute a single type of cancer
Study shows colon and rectal tumors constitute a single type of cancer — The Cancer Genome Atlas generates genomic data for colon and rectal cancers that point to potential targets for treatment – The pattern of genomic alterations in colon and rectal tissues is the same regardless of anatomic location or origin within the colon or the rectum, leading researchers to conclude that these two cancer types can be grouped as one, according to The Cancer Genome Atlas (TCGA) project’s large-scale study of colon and rectal cancer tissue specimens.
Lung cancer mortality linked to tobacco control efforts
Lung cancer mortality rates among young and middle-aged white women climb in some states — New analysis points to tobacco control efforts or lack thereof as likely cause – A new study comparing lung cancer mortality rates among women by year of birth shows dramatic differences in trends between states, likely reflecting the success or failure of tobacco control efforts. The study finds that while lung cancer mortality rates declined continuously by birth year for women born after the 1950s in California, rates in other states declined less quickly or even increased.
Bevacizumab with chemotherapy provides no survival benefit for lung cancer patients
Adding drug to standard chemotherapy provides no survival benefit for older lung cancer patients – Adding the drug bevacizumab (Avastin) to the standard chemotherapy regimen for non-small cell lung cancer (NSCLC) ? an approach approved by the FDA in 2006 ? did not lead to significantly increase survival rates for patients over the age of 65 enrolled in Medicare.
Cancer is preventable – Obstacles standing in the way of prevention of cancer
More than half of all cancer is preventable — Public health researchers outline obstacles standing in the way of prevention – More than half of all cancer is preventable, and society has the knowledge to act on this information today. Researchers outline obstacles they say stand in the way of making a huge dent in the cancer burden in the United States and around the world.
Postoperative radiotherapy does not improve survival in lung cancer patients
Common postoperative radiotherapy does not improve survival in older people with lung cancer – Post-operative radiation therapy (PORT), a controversial yet frequently administered treatment for lung cancer, may not prolong life in older people with locally advanced disease.
New lung cancer test could accurately guide treatment for people with lung cancer
New lung cancer test predicts survival — Clinical studies in US and China show molecular test could more accurately guide treatment for people with lung cancer – In the two largest clinical studies ever conducted on the molecular genetics of lung cancer, an international team led by scientists at the University of California, San Francisco (UCSF) has demonstrated that an available molecular test can predict the likelihood of death from early-stage lung cancer more accurately than conventional methods.
35 new drugs approved in 2011 in US
FDA: 35 innovative new drugs approved in fiscal year 2011 — Report shows quick approvals of safe and effective medicines occur in the United States before other countries – Over the past 12 months, the U.S. Food and Drug Administration approved 35 new medicines for patients, like two new treatments for hepatitis C; a drug for late-stage prostate cancer; the first new drug for Hodgkin’s lymphoma in 30 years; and the first new drug for lupus in 50 years.